Description: Navicixizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting DLL4/VEGFA, for ..
US$478.50
(100 µg)
Buy it NOW
Showing 1 to 2 of 2 (1 Pages)
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.